Is EC 810-248-9 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EC 810-248-9? Is EC 810-248-9 safe for nursing mother and child? Does EC 810-248-9 extracts into breast milk? Does EC 810-248-9 has any long term or short term side effects on infants? Can EC 810-248-9 influence milk supply or can EC 810-248-9 decrease milk supply in lactating mothers?
EC 810-248-9 lactation summary
- DrLact safety Score for EC 810-248-9 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EC 810-248-9 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EC 810-248-9 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EC 810-248-9 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EC 810-248-9 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EC 810-248-9 usage in lactation
EC 810-248-9 or S-licarbazepine is the S-enantiomer of licarbazepine (MHD), the active metabolite of oxcarbazepine (see specific information), an anti-epileptic drug considered to be of low risk during breastfeeding. Since the last update we have not found any published data on its excretion in breast milk. Given the structural equivalence and similar actions to oxcarbazepine, different effects are not likely in infants who are breastfed by mothers undergoing treatment with EC 810-248-9 or oxcarbazepine, but until there is more data on this drug in relation to breastfeeding, safer known alternatives are preferred, especially in the neonatal period and in case of prematurity.
Answer by DrLact: About EC 810-248-9 usage in lactation
No information is available on the use of EC 810-248-9 during breastfeeding. However, EC 810-248-9 is the active metabolite of oxcarbazepine. Limited information indicates that oxcarbazepine would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants.
EC 810-248-9 Side Effects in Breastfeeding
No specific information is available in mothers taking EC 810-248-9. See the LactMed record on oxcarbazepine for relevant information.
Alternate Drugs
Eslicarbazepine(Low Risk)
Lamotrigine(Low Risk)
Vigabatrin(Safe)
Gabapentin(Safe)
Clobazam(Low Risk)
Felbamate(Unsafe)
Pregabalin(Low Risk)
Ethosuximide(Unsafe)
Acetazolamide(Safe)
Clonazepam(Low Risk)
Magnesium Sulfate(Safe)
Carbamazepine(Safe)
Zonisamide(Low Risk)
Valproic Acid(Safe)
Riluzole(Unsafe)
Topiramate(Safe)
Primidone(Low Risk)
Lacosamide(Unsafe)
Phenytoin(Safe)
Phenobarbital(Low Risk)
Oxcarbazepine(Safe)
Levetiracetam(Safe)